Sera Prognostics首席科学官出售价值$8,503股票
盐湖城讯—市值1.46亿美元、目前股价为$4.32的Sera Prognostics, Inc.（NASDAQ:SERA）近期出现内部人士交易活动。根据Form 4文件显示，公司首席科学官John J. Boniface于2025年3月6日以每股$4.16的加权平均价格出售了2,044股A类普通股，总计$8,503。 InvestingPro ...
Sera Prognostics首席信息官Gardner出售价值$15,450股票
据美国证券交易委员会的Form 4文件显示，Sera Prognostics, Inc. (NASDAQ: SERA )首席信息官Harrison Robert Gardner于2025年2月13日出售了部分公司股份。Gardner以加权平均价格$4.28出售了3,610股A类普通股，交易总额约为$15,450。根据 InvestingPro ...
美股内部交易 | Sera Prognostics于3月10日披露3笔公司内部人交易情况
2025年3月10日， Sera Prognostics（SERA）披露3笔公司内部人交易情况。董事Lindgardt Zhenya于2025年3月7日卖出2.97万股。 Sera Prognostics, Inc.于2008年1月17日根据特拉华州法律注册成立。该公司是一家女性健康诊断公司，利用公司专有的蛋白质组学和生物信息学平台来发现、开发和商业化具有临床意义和经济影响的生物标志物测试 ...
来自MSN1 个月
Sera Prognostics dips 5%, prices $50M offering
Sera Prognostics (NASDAQ:SERA) priced its underwritten public offering of 1.25M shares at a public offering price of $4.00 per share, pre-funded warrants to purchase 11.25M shares at $3.9999 per ...
来自MSN1 个月
Sera Prognostics CFO sells $27,090 in stock
SALT LAKE CITY—Aerts Austin, the Chief Financial Officer of Sera Prognostics , Inc. (NASDAQ:SERA), a company with a market capitalization of $137.45 million, executed a stock sale valued at ...
Wall Street Journal1 个月
Sera Prognostics Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
ETF Daily News7 天
Sera Prognostics (SERA) to Release Quarterly Earnings on Wednesday
Sera Prognostics has a 12 month low of $3.84 and a 12 month high of $12.36. The stock has a market capitalization of $142.52 million, a PE ratio of -4.26 and a beta of 0.89.
Wall Street Journal1 个月
Sera Prognostics Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
CNN2 年
Sera Prognostics, Inc. Class A
Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm ...
Investing13 天
Sera Prognostics at TD Cowen: Innovative Approaches to Preterm Birth
On Wednesday, 05 March 2025, Sera Prognostics (NASDAQ: SERA) participated in the TD Cowen 45th Annual Healthcare Conference, where President and CEO Zaina Lingard discussed the company’s ...
Nasdaq26 天
Sera Prognostics To Present at TD Cowen 45th Annual Health Care Conference
SALT LAKE CITY, Feb. 21, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy ...